Cholestech provides diagnostic tools and information to health care practitioners in more than 35 countries worldwide. It offers diagnostic testing for cholesterol, lipids, blood glucose, liver enzymes and glycemic control. The company also provides risk assessment and therapeutic monitoring solutions for heart disease and diabetes. Its products, Cholestech LDX and Cholestech GDX systems, are approved by the Food & Drug Administration (FDA) to be used for monitoring the progress of patient therapy. Its Cholestech GDX system, a hemoglobin A1C testing system is comprised of GDX analyzer, single-use test cartridges and related accessories that indicate blood sugar control over last two and three months. Cholestech sells products throughout the United States, as well as Europe, Asia, South America and Australia through a network of distributors.